Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
149.5 INR | -0.23% | -3.05% | +7.67% |
05-14 | Jefferies Adjusts Piramal Pharma’s Price Target to INR180 From INR170, Keeps at Buy | MT |
05-13 | Transcript : Piramal Pharma Limited, Q4 2024 Earnings Call, May 13, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+7.67% | 2.38B | |
+32.09% | 693B | |
+29.39% | 584B | |
-1.34% | 372B | |
+20.34% | 332B | |
+7.39% | 294B | |
+14.25% | 239B | |
-3.03% | 211B | |
+10.02% | 210B | |
+8.49% | 168B |
- Stock Market
- Equities
- PPLPHARMA Stock
- News Piramal Pharma Limited
- Jefferies Adjusts Piramal Pharma’s Price Target to INR125 From INR115, Keeps at Buy